This topic contains a solution. Click here to go to the answer

Author Question: Which of the following conditions does not predispose to edema? A. Heart failure B. Chronic ... (Read 44 times)

cdr_15

  • Hero Member
  • *****
  • Posts: 546
Which of the following conditions does not predispose to edema?
 
  A. Heart failure
  B. Chronic emotional stress
  C. Increased capillary permeability
  D. Low plasma osmotic pressure resulting from low blood proteins

Question 2

The firm, fibrous outer membrane of the central nervous system is the __________.
 
  A. dura
  B. pia
  C. arachnoid
  D. subarachnoid space



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

k.lashomb

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

B

Answer to Question 2

A




cdr_15

  • Member
  • Posts: 546
Reply 2 on: Jun 25, 2018
Wow, this really help


samiel-sayed

  • Member
  • Posts: 337
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

Blood in the urine can be a sign of a kidney stone, glomerulonephritis, or other kidney problems.

Did you know?

Nitroglycerin is used to alleviate various heart-related conditions, and it is also the chief component of dynamite (but mixed in a solid clay base to stabilize it).

Did you know?

As the western states of America were settled, pioneers often had to drink rancid water from ponds and other sources. This often resulted in chronic diarrhea, causing many cases of dehydration and death that could have been avoided if clean water had been available.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library